Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Dec 5, 2022 OWNERSHIP DOCUMENT
8-K Nov 15, 2022 FORM 8-K
8-K Nov 14, 2022 8-K
10-Q Nov 14, 2022 10-Q
8-K Sep 16, 2022 FORM 8-K
4 Aug 16, 2022 OWNERSHIP DOCUMENT
3 Aug 16, 2022 OWNERSHIP DOCUMENT
8-K Aug 16, 2022 FORM 8-K
8-K Aug 11, 2022 8-K
10-Q Aug 11, 2022 10-Q
8-K Jun 9, 2022 8-K
S-8 May 12, 2022 FORM S-8
8-K May 12, 2022 8-K
10-Q May 12, 2022 10-Q
DEFA14A Apr 25, 2022 DEFA14A
DEF 14A Apr 25, 2022 DEF 14A
8-K Apr 6, 2022 FORM 8-K
424B5 Apr 1, 2022 424B5
8-K Apr 1, 2022 FORM 8-K
424B5 Mar 31, 2022 424B5
8-K Mar 31, 2022 FORM 8-K
10-K Mar 31, 2022 10-K
4 Mar 15, 2022 OWNERSHIP DOCUMENT
3 Mar 14, 2022 OWNERSHIP DOCUMENT
4 Feb 1, 2022 OWNERSHIP DOCUMENT
← Newer Page 8 of 51 · 1272 filings Older →